Making every day a better day for people with diabetes. Welcome to our community.
Our connected diabetes ecosystem of care helps diabetes fade into the background, allowing for more confidence and spontaneity through the day.
30/03/2026
New round of guess my diabetes gear!
Today’s entries include:
The key that unlocks the battery.
The papers that check your blood pressure (personal fav).
The thing you leave everywhere.
Why are these somehow… accurate?
We love this game!
23/03/2026
POV: you were so busy living…
you forgot you had diabetes today.
We love seeing our MiniMed Champion Montana thriving on the MiniMed™ 780G System^.
ALWAYS FOLLOW THE DIRECTIONS FOR USE
The MiniMed™ 780G system is indicated for use by individuals aged 2 years and older with insulin-requiring diabetes, whose total daily dose of insulin is 6 units per day or more. The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to provide an automatic adjustment of insulin delivery based on continuous glucose monitoring (CGM) and can suspend the delivery of insulin when the SG value falls below, or is predicted to fall below, predefined threshold values.
Automated insulin delivery is made possible through combining MiniMed™ insulin pump and continuous glucose monitoring technology. Some user interaction required. Individual responses to the treatment can and do vary. Consult a healthcare professional to see if this product is suitable for you.
The Guardian™ 4 sensor is intended for use with the Guardian™ 4 transmitter and indicated for measuring interstitial-fluid glucose levels in people with insulin-requiring diabetes where self-monitoring of blood glucose (SMBG) is indicated. The sensor is a single-use, disposable device intended to be paired with a compatible transmitter as part of a continuous glucose monitoring (CGM) system for the management of diabetes. The sensor and transmitter CGM system is a non-adjunctive system that may replace fingerstick blood glucose readings for treatment decisions. The sensor is indicated for single patient use in persons 2 years and older with diabetes mellitus. The sensor is intended for insertion into the back of the upper arm or the upper buttocks in persons ages 2 through 17 years. The sensor is intended for insertion into the back of the upper arm or the abdomen in persons ages 18 years and older. If glucose values do not match expectations, use a blood glucose meter to make diabetes treatment decisions.
^ Components sold separately
This testimonial relates to a genuine account of an individual’s response to the treatment, and does not provide any indication guide, warranty or guarantee as to the response other persons have to the treatment.
Calling all teens living with type 1 — Camp Koala 2026 is your chance to build confidence, back yourself, and make lifelong friends who truly get it. Adventure, independence and unforgettable beach memories await.
🗓️ 11–15 April 2026
📍Anglesea, VIC
09/03/2026
We’re thrilled to announce that we are now MiniMed! We’re excited for this new chapter in serving the diabetes community as a standalone, public company. Our Mission is to make every day a better day for people with . Dedicated to advancing technology and care, our connected diabetes ecosystem will take on more of the work, so you can enjoy exciting, messy, spontaneous, fully lived days. After all, that’s what life is all about.
MiniMed. Better days start today!
09/02/2026
I expected compromise. What I got was flexibility.
Band on, clipped on, or in my pocket!
My MM780G System^ fits into my life, not the other way around.
And that changes everything.
We love to see you thriving!!!
This testimonial relates to a genuine account of an individual’s response to the treatment, and does not provide any indication, guide, warranty, or guarantee as to the response other persons have to the treatment.
ALWAYS FOLLOW THE DIRECTIONS FOR USE
The MiniMed™ 780G system is indicated for use by individuals aged 2 years and older with insulin-requiring diabetes, whose total daily dose of insulin is 6 units per day or more. The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to provide an automatic adjustment of insulin delivery based on continuous glucose monitoring (CGM) and can suspend the delivery of insulin when the SG value falls below, or is predicted to fall below, predefined threshold values.
Automated insulin delivery is made possible through combining Medtronic insulin pump and continuous glucose monitoring technology. Some user interaction required. Individual responses to the treatment can and do vary Consult a healthcare professional to see if this product is suitable for you.
The Guardian™ 4 sensor is intended for use with the Guardian™ 4 transmitter to monitor glucose levels in persons with diabetes where self-monitoring of blood glucose (SMBG) is indicated. The sensor is a single-use, disposable device intended to be paired with a compatible transmitter as part of a continuous glucose monitoring (CGM) system for the management of diabetes. The sensor and transmitter CGM system is a non-adjunctive system that may replace fingerstick blood glucose readings for treatment decisions. The Sensor is indicated for single patient use in persons 2 years and older with diabetes mellitus. The sensor is intended for insertion into the back of the upper arm or the upper buttocks in persons ages 2 through 17 years. The sensor is intended for insertion into the back of the upper arm or the abdomen in persons ages 18 years and older.
^ Components sold separately
02/02/2026
POV: you forgot you even have type 1 diabetes today.
You danced in the rain.
You experienced a tea ceremony in Japan.
You performed on stage.
You celebrated your engagement surrounded by cannoli and cupcakes.
Type 1 didn’t interrupt a single moment; Life doesn’t pause and neither do our MiniMed Champions
This testimonial relates to a genuine account of an individual's response to the treatment, and does not provide any indication guide, warranty or guarantee as to the response other persons have to the treatment.
ALWAYS FOLLOW THE DIRECTIONS FOR USE.
For detailed information regarding indications, contraindications, warnings, precautions, and potential adverse effects, please consult the information for use at: www.medtronicdiabetes.com.au/
Medtronic’s (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with Type 1 diabetes. MiniMed 780G is indicated for patients 7-80 years with Type 1 diabetes and whose total daily dose of insulin are 8 units per day or more. Guardian™ Sensor 4 may also be used as part of the MiniMed® 780G system^ for people living with Type 1 diabetes age 7 and up. If sensor glucose (SG) values do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide.
^ Components sold separately.
26/01/2026
"I've always felt like you could do anything with diabetes. Type 1 diabetes 24 years ago and now are very different, and technology has evolved with MiniMed. Don't be scared of what might hold you back, there are no limits to what you can achieve.” - Alexander Zverev
Every journey with diabetes looks different but progress, support, and belief can make a difference!
15/01/2026
Type 1 diabetes doesn’t look one way.
And it doesn’t shape one kind of life.
From centre court to the footy field, and the dance floor Alexander Zverev, Paddy McCartin and Alexia show what’s possible when lived experience is met with courage, support and resilience.
We brought this incredible panel together in Melbourne for an exclusive event to do more than tell stories. We are raising awareness, making the invisible, VISIBLE and having honest conversations about the realities of living with type 1 diabetes.
T1d is widely misunderstood. When people are supported, seen and given access, they can live full ambitious lives without limits!
*Paid Partnership
This testimonial relates to a genuine account of an individual’s response to the treatment, and does not provide any indication guide, warranty or guarantee as to the response other persons have to the treatment.
ALWAYS FOLLOW THE DIRECTIONS FOR USE.
For detailed information regarding indications, contraindications, warnings, precautions, and potential adverse effects, please consult the information for use at: www.medtronicdiabetes.com.au/
Medtronic’s (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with Type 1 diabetes. MiniMed 780G is indicated for patients 7-80 years with Type 1 diabetes and whose total daily dose of insulin are 8 units per day or more. Guardian™ Sensor 4 may also be used as part of the MiniMed® 780G system^ for people living with Type 1 diabetes age 7 and up. If sensor glucose (SG) values do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide.
^ Components sold separately..
12/01/2026
I was diagnosed with Type 1 Diabetes at 4 years old — scared, overwhelmed, and just wanting life to feel “normal” again. What I didn’t know then was how much this journey would shape me — not by limiting me, but by building resilience, discipline, and drive.
T1D is constant — 24/7, 365 days a year—every decision matters. There’ve been ambulance rides, sleepless nights, and moments that tested me. But my family, friends, and healthcare team have always had my back.
Now, two decades later, I’m thriving — competing in basketball, studying, travelling, hitting goals in the gym, and even modelling and acting. Diabetes may influence my life, but it doesn’t define it.
If I could talk to my younger self, I’d say:
“You’ve got this. Every challenge will build your strength. Diabetes will shape you — but it will never limit you.”
Thank you for sharing your story with us Ethan, you inspire us every day
This testimonial relates to a genuine account of an individual’s response to the treatment, and does not provide any indication guide, warranty or guarantee as to the response other persons have to the treatment.
Always consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to the therapy, or products discussed.
05/01/2026
We’re inspired by — a reminder that progress isn’t about perfection, it’s about showing up.
Because your health — and your future — are worth it 💙
ALWAYS FOLLOW THE DIRECTIONS FOR USE
For detailed information regarding indications, contraindications, warnings, precautions, and potential adverse effects, please consult the instructions for use at: www.medtronicdiabetes.com.au/
Medtronic’s (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with Type 1 diabetes. MiniMed 780G is indicated for patients 7-80 years with Type 1 diabetes and whose total daily dose of insulin are 8 units per day or more. Guardian™ Sensor 4 may also be used as part of the MiniMed® 780G system^ for people living with Type 1 diabetes age 7 and up. If sensor glucose (SG) values do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide.
^ Components sold separately.
This testimonial relates to a genuine account of an individual's response to the treatment, and does not provide any indication guide, warranty or guarantee as to the response other persons have to the treatment. Always consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to the therapy, or products discussed.
24/12/2025
💙 From our hearts to yours 💙
This holiday season, the wishes are simple:
✨ More stability
✨ Fewer worries
✨ Extra freedom to enjoy every moment
Whether you’re relaxing, reconnecting, or recharging — here’s to celebrating the little wins, sharing laughter, and living life in balance.
Happy holidays to our incredible T1D community!
22/12/2025
Packing for take-off hits different with T1D ✈️
From snacks to sensors and everything in between — here’s a little guide to get you started (yours will look a bit different, and that’s okay!)
Address
Level 8, 11 Khartoum Road Macquarie Park, NSW 2113
Be the first to know and let us send you an email when MiniMed Australia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
With over 30 years experience creating revolutionary products; Medtronic is the leader in diabetes management technology.
CUSTOMER SERVICE
Medtronic offers 24/7 support to help you with your diabetes management. As you commence your journey with insulin pump therapy, Medtronic will proudly partner you in better control. Our support services have been designed to provide you with the highest level of customer service, including:
access to Medtronic Clinical Specialists
access to Certified Pump Trainers
a dedicated 24 hour global help line
a travel loan program
TECHNOLOGY
Medtronic has the first available integrated system to help you better control your diabetes simply and effectively. Our truly integrated diabetes management system includes an Insulin Pump, CONTOUR™ NEXT LINK blood glucose meter, CGM and complimentary CareLink™ Personal therapy management software. Clinical trials have demonstrated that each component in the Medtronic integrated system can help lower HbA1c 1,2,3
Medtronic MiniMed® 670G System^ is the only available product listed on the Prostheses List with SmartGuard® Auto-Mode technology.**
We're the pioneer and leader in providing continuous glucose monitoring systems with more than 7 million sensors sold worldwide.
Globally Medtronic Diabetes invests over $100 million per year in research and development to help advance the goal of making an artificial pancreas a reality.
EDUCATION AND TRAINING
We are committed to providing you with the latest information and education, personally through our information events and education sessions, and online via our YouTube channel, webinars and learning modules. Our clinical support staff are dedicated to helping you get the most out of your pump and you also have access to our certified pump trainers.